Public, NASDAQ:MEDX
NASDAQ Global Market
Medarex Inc (MEDX) completely dumped by Denali Advisors Llc
Date: Thu, 24 Jul 2008 14:22:17 GMT
Tags:
Medarex Inc (MEDX) completely dumped by Denali Advisors Llc
Mffais.com - 13 hours ago
Mffais.com - 13 hours ago
LONG BEACH ( Mffais . com ) - Denali Advisors Llc completely dumped all - 2,400 shares they owned of Medarex Inc ( MEDX ) as shown by filings made public on 2008 - 07 - 23.The stock is currently ...
Medarex Receives Milestone Payment for Acceptance of Investigational New Drug Application
Date: Thu, 24 Jul 2008 10:14:01 GMT
Tags:
Medarex Receives Milestone Payment for Acceptance of Investigational New Drug Application
Lifescience-online - 18 hours ago
Lifescience-online - 18 hours ago
Medarex , Inc . today announced that it has received a milestone payment of an undisclosed amount from its licensing partner , Centocor R and D Inc . , for the acceptance of an Investigational ...
Biopharma Firm Earns Pay Day from J&J Subsidiary
Date: Wed, 23 Jul 2008 17:50:01 GMT
Tags:
Biopharma Firm Earns Pay Day from J&J Subsidiary
NJBIZ - Jul 23, 2008
NJBIZ - Jul 23, 2008
Princeton biopharmaceutical company Medarex , Inc . ( NASDAQ : MEDX ) said today it has received a milestone payment from licensing partner Centocor R&D Inc . , a Johnson & Johnson subsidiary.The ...
Medarex Receives Milestone Payment for Acceptance of Investigational New Drug Application
Date: Wed, 23 Jul 2008 14:08:39 GMT
Tags:
Medarex Receives Milestone Payment for Acceptance of Investigational New Drug Application
PR Newswire (press release) - Jul 23, 2008
PR Newswire (press release) - Jul 23, 2008
PRINCETON , NJ , July 23 / PRNewswire - FirstCall / - - Medarex , Inc . ( NASDAQ : MEDX ) today announced that it has received a milestone payment of an undisclosed amount from its licensing ...
Medarex obtains milestone payment for acceptance of Investigational New Drug Application
Date: Wed, 23 Jul 2008 13:46:32 GMT
Tags:
Medarex obtains milestone payment for acceptance of Investigational New Drug Application
RTT News - Jul 23, 2008
RTT News - Jul 23, 2008
( RTTNews ) - Medarex , Inc . ( MEDX : News , Chart , Quote ) announced that it received a milestone payment of an undisclosed amount from its licensing partner , Centocor R&D Inc . , for the ...
Medarex Receives Milestone Payment for Acceptance of Investigational New Drug Application (PR Newswire)
Date: Wed, 23 Jul 2008 12:00:00 Etc/GMT
Tags:
Medarex, Inc. today announced that it has received a milestone payment of an undisclosed amount from its licensing partner, Centocor R&D Inc., for the acceptance of an Investigational New Drug Application to the U.S.
Feuerstein's Biotech-Stock Mailbag: Synta (at TheStreet.com)
Date: Fri, 18 Jul 2008 15:07:16 Etc/GMT
Tags:
BioWa and Medarex Announce License of BioWa's COMPLEGENT(TM) Technology (PR Newswire)
Date: Wed, 16 Jul 2008 10:00:00 Etc/GMT
Tags:
BioWa, Inc. and Medarex, Inc. announced today that they have entered into a license agreement which provides Medarex with the first ever access to BioWa's COMPLEGENT Technology for enhancing the complement-dependent cytotoxicity of select Medarex therapeutic antibodies.
Will a New Use Help Schering-Plough's Near-Blockbuster Drug? (at Motley Fool)
Date: Tue, 15 Jul 2008 13:45:50 Etc/GMT
Tags:
Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City (PR Newswire)
Date: Thu, 10 Jul 2008 19:54:00 Etc/GMT
Tags:
Medarex, Inc. today provided a detailed overview of the company's strategy, strength in research discovery and antibody development, and the multiple opportunities Medarex is engaged in for creating long-term value.